ISPOR’s New 2030 Strategy: Raising the Global Profile and Impact of HEOR
Author(s)
Eberechukwu Onukwugha, PhD, University of Maryland School of Pharmacy, Baltimore, MD, USA, Rob Abbott, -, CEO & Executive Director, ISPOR, Lawrenceville, NJ, USA, Brian O'Rourke, PhD, RCMS, Ottawa, ON, Canada, Laura Pizzi, PharmD, MPH, Chief Science Officer, ISPOR, Lawrence Township, NJ, USA and Mitchell Higashi, PhD, Associate Chief Science Officer, ISPOR, Lawrenceville, NJ, USA
Join us for an exclusive Connection Zone session led by ISPOR executive leadership as we take a deep dive into ISPOR’s new Strategic Plan 2030. During this session, attendees will learn about ISPOR’s bold new vision, mission, and core values, as well as the overarching goals and objectives we will be pursuing over the next 5-6 years. Attendees will be encouraged to engage in an open dialogue and share their ideas about how to implement the plan.
Conference/Value in Health Info
2024-11, ISPOR Europe 2024, Barcelona, Spain
Code
135
Topic
Organizational Practices